BiomarkersHumans
Alterations in cortical excitability and plasticity are associated with amyloid accumulation in cognitively unimpaired elderly
AAIC 2025 Abstract
Abstract
Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by early amyloid‐beta (Aβ) accumulation, which can precede clinical symptoms by years. Plasma Aβ42/Aβ40 oligomers have emerged as a surrogate biomarker for brain amyloid, providing a non‐invasive method to identify individuals at high risk.
The paper
Beth Israel Deaconess Medical Center
AAIC 2025 Abstract · 7 Jan 2026 · CC BY
Presented at AAIC 2025


